Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J De Feo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Viruses|January 25, 2013
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitorsChristopher J De Feo, Carol D Weiss
The Journal of Membrane Biology|March 13, 2010
Tryptophan scanning analysis of the membrane domain of CTR-copper transportersChristopher J De Feo, Sara Mootien, Vinzenz M Unger
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 11, 2007
A structural perspective on copper uptake in eukaryotesChristopher J De Feo, Stephen G Aller, Vinzenz M Unger
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Cellular distribution of copper to superoxide dismutase involves scaffolding by membranesChristopher R Pope, Christopher J De Feo, Vinzenz M Unger
The Journal of Biological Chemistry|September 24, 2004
Eukaryotic CTR copper uptake transporters require two faces of the third transmembrane domain for helix packing, oligomerization, and functionStephen G Aller, Edward T Eng, Christopher J De Feo, et al.
Journal of Virology|October 14, 2011
Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HR2) of gp41Wei Wang, Christopher J De Feo, Min Zhuang, et al.
The Journal of Biological Chemistry|January 12, 2012
Trimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathwaysMin Zhuang, Wei Wang, Christopher J De Feo, et al.
Retrovirology|October 3, 2014
Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kineticsChristopher J De Feo, Wei Wang, Meng-Lun Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2009
Three-dimensional structure of the human copper transporter hCTR1Christopher J De Feo, Stephen G Aller, Gnana S Siluvai, et al.
Plos Pathogens|June 23, 2011
Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2Wei Wang, Christine M Anderson, Christopher J De Feo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Viruses|January 25, 2013
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitorsChristopher J De Feo, Carol D Weiss
The Journal of Membrane Biology|March 13, 2010
Tryptophan scanning analysis of the membrane domain of CTR-copper transportersChristopher J De Feo, Sara Mootien, Vinzenz M Unger
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 11, 2007
A structural perspective on copper uptake in eukaryotesChristopher J De Feo, Stephen G Aller, Vinzenz M Unger
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Cellular distribution of copper to superoxide dismutase involves scaffolding by membranesChristopher R Pope, Christopher J De Feo, Vinzenz M Unger
The Journal of Biological Chemistry|September 24, 2004
Eukaryotic CTR copper uptake transporters require two faces of the third transmembrane domain for helix packing, oligomerization, and functionStephen G Aller, Edward T Eng, Christopher J De Feo, et al.
Journal of Virology|October 14, 2011
Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HR2) of gp41Wei Wang, Christopher J De Feo, Min Zhuang, et al.
The Journal of Biological Chemistry|January 12, 2012
Trimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathwaysMin Zhuang, Wei Wang, Christopher J De Feo, et al.
Retrovirology|October 3, 2014
Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kineticsChristopher J De Feo, Wei Wang, Meng-Lun Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2009
Three-dimensional structure of the human copper transporter hCTR1Christopher J De Feo, Stephen G Aller, Gnana S Siluvai, et al.
Plos Pathogens|June 23, 2011
Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2Wei Wang, Christine M Anderson, Christopher J De Feo, et al.
Pageof 1